Karyopharm Shares Drop Following Executive Retention Payouts

The 2026 Leadership Cash Retention Program triggers significant payouts for four senior executives, led by Chief Executive Officer Richard Paulson, who is set to receive more than $1.7 million. Other recipients include Chief Medical Officer Reshma Rangwala at $725,000, Chief Development Officer Stuart Poulton at $640,000, and Chief Financial Officer Lori Macomber at $625,000.

Karyopharm maintains that these awards are necessary to stabilize its core team during an upcoming stretch of critical corporate milestones. In its filing, the company stated that retaining experienced leadership is vital as it prepares for several meaningful catalysts ahead. Despite the market's negative reaction, the stock had previously enjoyed a 29% climb throughout the year prior to the announcement.